UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 12.

Varga, Z; Gaspert, A; Behnke, S; von Teichman, A; Fritzsche, F R; Fehr, T (2012). Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology. Pathology international, 62(4):254-263.

Varga, Z; Moelans, C B; Zuerrer-Hardi, U; Ramach, C; Behnke, S; Kristiansen, G; Moch, H (2012). Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. Breast Cancer Research and Treatment, 133(3):929-935.

Arbogast, S; Behnke, S; Opitz, I; Stahel, R A; Seifert, B; Weder, W; Moch, H; Soltermann, A (2011). Automated ERCC1 Immunohistochemistry in Non-small Cell Lung Cancer: Comparison of anti-ERCC1 Antibodies 8F1, D-10, and FL-297. Applied Immunohistochemistry & Molecular Morphology, 19(2):99-105.

Soltermann, A; Kilgus-Hawelski, S; Behnke, S; Storz, M; Moch, H; Bode, B (2011). Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10. Journal of Clinical Bioinformatics, 1:25.

Gerhardt, J; Steinbrech, C; Büchi, O; Behnke, S; Bohnert, A; Fritzsche, F; Liewen, H; Stenner, F; Wild, P; Hermanns, T; Müntener, M; Dietel, M; Jung, K; Stephan, C; Kristiansen, G (2011). The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro. American Journal of Pathology, 178(4):1847-1860.

Teichman, A V; Compérat, E; Behnke, S; Storz, M; Moch, H; Schraml, P (2011). VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma. Modern Pathology, 24(4):571-578.

Theurillat, J P; Dreier, B; Nagy-Davidescu, G; Seifert, Burkhardt; Behnke, S; Zürrer-Härdi, U; Ingold, F; Plückthun, A; Moch, H (2010). Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer. Modern Pathology, 23(9):1289-1297.

Ikenberg, K; Fritzsche, F R; Zuerrer-Haerdi, U; Hofmann, I; Hermanns, T; Seifert, H; Müntener, M; Provenzano, M; Sulser, T; Behnke, S; Gerhardt, J; Mortezavi, A; Wild, P; Hofstädter, F; Burger, M; Moch, H; Kristiansen, G (2010). Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer, 10:341.

Grass, B; Wachtel, M; Behnke, S; Leuschner, I; Niggli, F K; Schäfer, B W (2009). Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics. Histopathology, 54(7):873-879.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Weber, A; Kristiansen, I; Johannsen, M; Oelrich, B; Scholmann, K; Gunia, S; May, M; Meyer, H A; Behnke, S; Moch, H; Kristiansen, G (2008). The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer, 8:369:1-11.

Baenziger, S; Tussiwand, R; Schlaepfer, E; Mazzucchelli, L; Heikenwalder, M; Kurrer, M O; Behnke, S; Frey, J; Oxenius, A; Joller, H; Aguzzi, A; Manz, M G; Speck, R F (2006). Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 103(43):15951-15956.

This list was generated on Tue Jul 25 09:03:22 2017 CEST.